Dr. Andrew Aschenbrenner's lab focuses on improving cognitive monitoring for patients undergoing treatment for Alzheimer's disease. The team is developing a smartphone-based system to detect cognitive changes that may occur due to treatment side effects, specifically amyloid-related imaging abnormalities. This project aims to make cognitive assessments more accessible and less burdensome for patients, ultimately enhancing treatment safety and effectiveness.

Dr. Jaime Perales Puchalt's lab focuses on developing innovative solutions to support Latino caregivers of individuals with Alzheimer's disease and related dementias. They have created a bilingual text message intervention called CuidaTEXT, which aims to improve mental health outcomes for caregivers by providing tailored support and resources. The lab conducts clinical trials to evaluate the efficacy of this intervention and its impact on caregiver stress and well-being.

Dr. Jeffrey Statland's research lab focuses on improving treatments for facioscapulohumeral muscular dystrophy (FSHD), a genetic muscle disorder that primarily affects children and young adults. The lab aims to validate clinical outcome measures and biomarkers that can help in the development of effective therapies. By conducting prospective studies on pediatric FSHD, the lab hopes to enhance the understanding of the disease and accelerate the process of bringing new treatments to patients.

Dr. Eric Dennis Vidoni's lab at the University of Kansas Medical Center focuses on understanding how different types of exercise impact brain health and cognition in older adults. Their research investigates the effects of aerobic and resistance training on cognitive performance, brain structure, and overall physical function. By leveraging community-based exercise programs, they aim to develop strategies that promote successful aging and help prevent diseases like Alzheimer's.

Dr. Heather M. Wilkins leads a research lab at the University of Kansas Medical Center focusing on the role of amyloid precursor protein (APP) in mitochondrial function and mitophagy, particularly in the context of Alzheimer’s disease. The lab investigates how APP interacts with mitochondrial components to influence energy production and cellular health. This work has important implications for understanding Alzheimer’s disease and developing potential therapeutic strategies.